Back to UBS Group AG UBS Group AG

ATONATON
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in PORTAGE BIOTECH INC

Yes. Ubs holds 31,432 shares of ATON (Portage Biotech), worth $7,983, as of its Q2 2026 13F filing. It increased the position from 5,544 shares in Q1 2026. Ubs has held ATON since Q3 2024, across 8 quarterly 13F filings.

Current Value

$7,983

Current Shares

31,432

Total Value Change

-$8,416

Total Shares Change

+28,966

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
31,432
+467.0%
$7,9830.0%$12.70
18
2026-Q1
Increased
5,544
+3219.8%
$1,7520.0%$15.80
12
2025-Q4
Decreased
167
-22.0%
$1000.0%$30.00
0
2025-Q3
Decreased
214
-20.4%
$1,1530.0%$269.50
0
2025-Q2
Decreased
269
-97.4%
$1,4860.0%$276.00
0
2025-Q1
Increased
10,213
+184.0%
$94,4700.0%$462.50
24
2024-Q4
Increased
3,596
+45.8%
$18,5920.0%$258.50
17
2024-Q3
New
2,466
-
$16,3990.0%$332.50
28

Other major holders of ATON: JANE STREET GROUP, LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, Virtu Financial LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used